BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 18, 2013
View Archived Issues
Novartis develops new apoptosis regulators
Read More
CHF-5074 shows promising clinical efficacy in MCI
Read More
Gene linked to albuminuria in rat model
Read More
Tau-based immunotherapy for Alzheimer's disease described
Read More
LASSbio-1359 reverses development of PAH in rats
Read More
Dupilumab leads to improvements in eosinophilic asthma in phase IIa study
Read More
Daiichi Sankyo reports on in vivo studies of beta-amyloid peptide vaccine
Read More
Researchers develop novel transgenic mouse models of migraine-related disorders
Read More
Phase II study planned for CF-101 in uveitis
Read More
DSMB approves progress in three Advanced Cell Technology trials
Read More
FDA grants orphan designation to LJPC-0712 in Niemann-Pick type C disease
Read More
Adynxx receives FDA fast track designation for chronic pain treatment AYX1
Read More
ELND-005 granted FDA fast track designation for NPS in Alzheimer's disease
Read More
Spectrum Pharmaceuticals gains Marqibo with Talon Therapeutics acquisition
Read More
FDA accepts resubmission of NDA for Northera
Read More
Alkermes commences phase II study of broad-spectrum oral antipsychotic candidate
Read More
Compugen reveals new infrastructure platform for antibody discovery
Read More
New cationic polypeptides designed at the University of Minnesota
Read More
Rexahn in-licenses oncology drug delivery platform from University of Maryland, Baltimore
Read More
Novira Therapeutics prepares novel agents for HBV infection
Read More
Team of researchers in Brazil develop new vaccines for Brucella infection
Read More
Janssen and Pepscan patent novel polypeptide HIV fusion inhibitors
Read More
Novel lisuride analogues disclosed by MAP Pharmaceuticals, now part of Allergan
Read More
Alexion commences phase I trial of treatment candidate for MoCD
Read More
Recruitment begins in Boehringer Ingelheim's phase I trial of BI-409306
Read More
